USD 0.0
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 154.84 Thousand USD | 910970.59% |
2019 | -17.00 USD | -100.01% |
2018 | 140.87 Thousand USD | 9.75% |
2017 | 128.36 Thousand USD | 13.41% |
2016 | 113.17 Thousand USD | 11.31% |
2015 | 101.67 Thousand USD | 0.0% |
2007 | 2.25 Million USD | -3.79% |
2006 | 2.34 Million USD | 2644.76% |
2005 | 85.4 Thousand USD | 417.61% |
2004 | 16.5 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q1 | 295.94 USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 Q3 | 396.11 Thousand USD | -4.49% |
2021 FY | - USD | -100.0% |
2021 Q1 | 379.11 Thousand USD | 0.0% |
2021 Q2 | 414.75 Thousand USD | 9.4% |
2020 FY | 154.84 Thousand USD | 910970.59% |
2019 FY | -17.00 USD | -100.01% |
2018 FY | 140.87 Thousand USD | 9.75% |
2017 FY | 128.36 Thousand USD | 13.41% |
2016 FY | 113.17 Thousand USD | 11.31% |
2015 FY | 101.67 Thousand USD | 0.0% |
2008 Q2 | 2.81 Million USD | 13.4% |
2008 Q1 | 2.48 Million USD | 10.26% |
2007 Q2 | 2.57 Million USD | 10.11% |
2007 Q1 | 2.33 Million USD | -0.32% |
2007 FY | 2.25 Million USD | -3.79% |
2007 Q3 | 2.38 Million USD | -7.17% |
2007 Q4 | 2.25 Million USD | -5.57% |
2006 Q3 | 2.68 Million USD | 32.18% |
2006 Q4 | 2.34 Million USD | -12.61% |
2006 Q2 | 2.02 Million USD | 122.51% |
2006 Q1 | 912.04 Thousand USD | 967.9% |
2006 FY | 2.34 Million USD | 2644.76% |
2005 Q3 | 30.53 Thousand USD | -18.58% |
2005 Q1 | 34 Thousand USD | 0.0% |
2005 Q4 | 85.4 Thousand USD | 179.72% |
2005 Q2 | 37.5 Thousand USD | 10.29% |
2005 FY | 85.4 Thousand USD | 417.61% |
2004 FY | 16.5 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
American Medical Technologies Inc. | 479.63 Thousand USD | 100.0% |
Ansell Limited | -54.99 Million USD | 100.0% |
Ansell Limited | -55.1 Million USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | -36.49 Million USD | 100.0% |
CB Scientific, Inc. | -105.1 Thousand USD | 100.0% |
Psykey, Inc. | 634.59 Thousand USD | 100.0% |
ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
Encision Inc. | 1.29 Million USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 100.0% |
Innovative MedTech Inc. | 1.76 Million USD | 100.0% |
LifePoint, Inc. | -3.26 Million USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 2.16 Million USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | -43.3 Thousand USD | 100.0% |
Reflect Scientific, Inc. | -1.03 Million USD | 100.0% |
SmileDirectClub, Inc. | 778.67 Million USD | 100.0% |
Sector 10, Inc. | 163 Thousand USD | 100.0% |
Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.0% |
SheerVision, Inc. | 57.34 Thousand USD | 100.0% |
United Health Products, Inc. | 660.56 Thousand USD | 100.0% |
Vasamed, Inc. | 22.12 Thousand USD | 100.0% |
Wearable Health Solutions, Inc. | 2.63 Million USD | 100.0% |
Yubo International Biotech Limited | 772.27 Thousand USD | 100.0% |